Zurich, Switzerland, November 9, 2023 – DKSH’s Business Unit Performance Materials, a leading distributor of specialty chemicals and ingredients, will provide business development, marketing, sales, logistics, distribution services, product registration, and technical support for Pharmgate’s range of swine vaccines across four key markets in South-East Asia, namely Cambodia, Laos, Myanmar, and Thailand.
Pharmgate’s FDA- and USDA-approved manufacturing sites provide swine farmers with a variety of options for active ingredients, concentrations, administration routes, and monovalent/bivalent vaccines. Pharmgate’s comprehensive portfolio of intramuscular injections includes CircoGard, Circo/MycoGard, PRRSGard, MycoGard, and MycoGard-1.
DKSH has been chosen by Pharmgate to grow its pharmaceutical business for livestock in four key markets due to DKSH’s extensive distribution network, highly specialized commercial and technical teams, as well as its strong logistics capabilities and value-added services, including technical and regulatory support. By distributing these products in the markets, DKSH and Pharmgate can improve the welfare of farm animals together.
Leslie Gray, Global Distribution Manager, Pharmgate Animal Health, stated: “In forging this partnership with DKSH, we are excited to unite our strengths and commitment to the animal health industry. DKSH’s longevity and proven expertise in animal health align perfectly with Pharmgate’s dedication to delivering innovative solutions. Together, we embark on a journey to enhance the well-being of livestock and the success of our farming communities.”
Mathias Greger, Managing Director, Business Unit Performance Materials, Cambodia, Laos, Myanmar, and Thailand, DKSH, commented: “We are delighted to partner with Pharmgate in the four key South-East Asian markets. By leveraging DKSH’s strong capabilities in animal health and Pharmgate’s legacy of innovation and quality, we aim to provide high-quality products and increased benefits to farmers, veterinarians, and animal owners in the region.”
Pharmgate Animal Health provides the livestock and poultry industry with a proven portfolio of technically supported, high-quality products that are the foundation of the custom herd and flock health protocols. Founded in 2008, the company is headquartered in Wilmington, North Carolina, with FDA-approved pharmaceutical production facilities in Omaha, Nebraska, and CVM vaccine research and manufacturing operations in St. Paul, Minnesota. To learn more about Pharmgate Animal Health, or to find a local representative, visit www.pharmgate.com/global/
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 37 markets with 32,600 specialists, generating net sales of CHF 11.3 billion in 2022. The DKSH Business Unit Performance Materials distributes specialty chemicals and ingredients for food, pharmaceutical, personal care, and various industrial applications. With 53 innovation centers and regulatory support worldwide, we create cutting-edge formulations that comply with local regulations. With around 1,650 specialists, the Business Unit generated net sales of CHF 1.5 billion in 2022. www.dksh.com/pm
For more information please contact:
DKSH Performance Materials
Director, Group Marketing
Phone +44 20 8879 5500
Pharmgate Animal Health
Global Distribution Manager
Phone +35 38 7351 2708